We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved elafibranor (Iqirvo) to treat adult patients with a rare type of liver disease known as primary biliary cholangitis (PBC).
The UK chief medical officers and NHS England National Medical Director have given advice to help doctors wanting to take part in the assisted dying debate.
A new strategy is being published to radically cut the number of single-use medical devices in the health service.
Patient safety at heart of government’s plans for healthcare reform as Health and Social Care Secretary orders action to improve regulator performance.
Collaboration announced at International Investment Summit, meeting the PM's ambitions to catalyse investment in the UK and proving the UK is open for business.
Infected Blood Compensation Authority's newsletter that was circulated on 17 September 2024.
Infected Blood Compensation Authority's newsletter that was circulated on 10 October 2024.
The extension of the UN Disability Convention will protect the rights of over three thousand disabled people living in Bermuda.
Letter from the Independent Reconfiguration Panel Chair, Sir Norman Williams, to the Secretary of State for Health and Social Care, the Rt Hon Wes Streeting MP.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 10 October, approved an adapted Pfizer/BioNTech COVID-19 vaccine (Comirnaty) that targets the KP.2 COVID-19 subvariant for adults.
The Medicines and Healthcare products Regulatory Agency (MHRA) is asking patients who use a continuous glucose monitor (CGM) or insulin pump to report any safety problem with their device through the MHRA Yellow Card scheme …
All parents who have experienced losing a pregnancy can apply for a certificate formally recognising their loss, the government has announced.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today launched its ambitious new business plan for 2024/25, setting out the agency’s core focus of enabling access to innovative healthcare products while en…
Programme to help avoid brain injury in childbirth piloted from today to boost maternity safety.
The Health and Social Care Secretary spoke at the Royal College of General Practitioners (RCGP) annual conference 2024, in Liverpool.
The Health and Social Care Secretary confirmed the update during a speech at the Royal College of GPs’ conference in Liverpool.
Latest data from the UK Health Security Agency (UKHSA) also highlights that testing remains lower than before the COVID-19 pandemic.
UKHSA with DHSC and NHS launch Get Winter Strong campaign to remind those at risk to get their vaccinations to fight off the onslaught of winter viruses.
The Medicines and Healthcare products Regulatory Agency (MHRA) has on 25 September approved leniolisib phosphate (Joenja) to treat a rare immune disease known as activated phosphoinositide 3-kinase delta syndrome or APDS in…
UKHSA is advising students to use condoms when having sex with new or casual partners.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).